Sign in to view content

Episode 15: Serum VEGF Levels in the IVAN Trial with Dr. Usha Chakravarthy

Keyvan Koushan, MD, FRCSC

Audio
Published 2018

Related

Real World Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
Carl J Danzig, MD
Updates from the Field
2022
Wet AMD 2 Symposium
Annual Meeting Talks
2020
It’s the Patient, Not the Agent: An Assessment of Anti-VEGF Extended Dosing Intervals in Patients With nAMD
David A. Eichenbaum, MD, FASRS
On Demand Cases, Courses, and Papers
2019

Category: Pharmacology

See more